We are live on ! Find out more
SC

Stolper & Co Portfolio holdings

AUM $387M
1-Year Est. Return 25.53%
This Fund
S&P 500
This Quarter Est. Return
+15.01%
1 Year Est. Return
+25.53%
3 Year Est. Return
+70.5%
5 Year Est. Return
+93.54%
10 Year Est. Return
AUM
$178M
AUM Growth
+$23.6M
Cap. Flow
+$2.23M
Cap. Flow %
1.25%
Top 10 Hldgs %
34.27%
Holding
91
New
5
Increased
28
Reduced
54
Closed
3

Top Sells

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$5.79M
2
GILD icon
Gilead Sciences
GILD
+$1.04M
3
TGT icon
Target
TGT
+$454K
4
TTE icon
TotalEnergies
TTE
+$381K
5
MRK icon
Merck
MRK
+$251K

Sector Composition

Rank Sector Weight
1 Financials 20.02%
2 Technology 18.57%
3 Healthcare 10.97%
4 Energy 9.43%
5 Industrials 9.39%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BNY
26
Bank of New York Mellon
BNY
$108B
$2.62M 1.47%
61,780
-102
-0.2% -$3.92K
DHI icon
27
D.R. Horton
DHI
$41.2B
$2.52M 1.41%
+36,572
New +$2.67M
BP icon
28
BP
BP
$113B
$2.41M 1.35%
117,385
+14,779
+14% +$279K
ABBV icon
29
AbbVie
ABBV
$458B
$1.91M 1.07%
17,839
+273
+2% +$26.2K
CAT icon
30
Caterpillar
CAT
$409B
$1.84M 1.03%
10,134
+143
+1% +$24.3K
VZ icon
31
Verizon
VZ
$194B
$1.8M 1.01%
30,680
+600
+2% +$35.6K
HP icon
32
Helmerich & Payne
HP
$3.53B
$1.8M 1.01%
77,638
-2,780
-3% -$53.9K
DVY icon
33
iShares Select Dividend ETF
DVY
$24B
$1.73M 0.97%
+17,997
New +$1.63M
PG icon
34
Procter & Gamble
PG
$343B
$1.67M 0.94%
11,979
+218
+2% +$30.5K
BMY icon
35
Bristol-Myers Squibb
BMY
$127B
$1.62M 0.91%
26,088
+485
+2% +$29.8K
CVS icon
36
CVS Health
CVS
$137B
$1.59M 0.89%
23,302
+447
+2% +$29.1K
MRK icon
37
Merck
MRK
$324B
$1.59M 0.89%
20,321
-3,277
-14% -$251K
PFE icon
38
Pfizer
PFE
$140B
$1.58M 0.89%
42,875
-1,296
-3% -$47.5K
LYB icon
39
LyondellBasell Industries
LYB
$19.5B
$1.56M 0.87%
16,982
-331
-2% -$27K
DLR icon
40
Digital Realty Trust
DLR
$73.7B
$1.55M 0.87%
11,104
+195
+2% +$27.9K
STAG icon
41
STAG Industrial
STAG
$7.86B
$1.49M 0.84%
47,606
+998
+2% +$31.2K
T icon
42
AT&T
T
$165B
$1.47M 0.83%
67,700
+1,839
+3% +$39.7K
MCD icon
43
McDonald's
MCD
$188B
$1.44M 0.81%
6,718
+128
+2% +$27.8K
SO icon
44
Southern Company
SO
$110B
$1.41M 0.79%
22,990
+501
+2% +$30.1K
NEM icon
45
Newmont
NEM
$99.5B
$1.3M 0.73%
+21,718
New +$1.34M
PM icon
46
Philip Morris
PM
$301B
$1.27M 0.71%
15,307
+380
+3% +$29.6K
UL icon
47
Unilever
UL
$131B
$1.21M 0.68%
17,806
+474
+3% +$32.2K
TY icon
48
TRI-Continental Corp
TY
$1.86B
$1.13M 0.63%
38,359
MET icon
49
MetLife
MET
$61B
$1.13M 0.63%
24,054
-4,206
-15% -$182K
WBA
50
DELISTED
Walgreens Boots Alliance
WBA
$1.12M 0.63%
28,004
+3,479
+14% +$135K

Similar funds

Stolper & Co's Q4 2020 Portfolio in Review

As of Q4 2020, Stolper & Co held 91 positions worth $178M, up 15% from $155M the previous quarter. Its ten largest holdings account for 34% of the portfolio.

Stolper & Co's Q4 2020 filing shows 5 new, 28 increased, 54 reduced and 3 closed positions. Its largest new stake was Northrop Grumman: 13,031 shares worth $3.97M. The largest sale was Apple, an estimated $5.79M.

By sector, the portfolio is most concentrated in Financials at 20% of assets, up from 19% a quarter earlier, followed by Technology and Healthcare.

  • Stolper & Co's largest Q4 2020 buy was Northrop Grumman: 13,031 shares worth $3.97M.
  • Stolper & Co added most to Phillips 66 in Q4 2020, an estimated $542K increase.
  • Stolper & Co's biggest Q4 2020 reduction was Apple, cutting an estimated $5.79M.
  • Stolper & Co fully exited Gilead Sciences in Q4 2020, selling an estimated $1.04M.
  • Stolper & Co's ten largest holdings make up 34% of its $178M portfolio in Q4 2020.
  • Stolper & Co opened 5 new positions and closed 3 in Q4 2020.
  • Stolper & Co's portfolio value rose 15% quarter-over-quarter to $178M.

Based on Stolper & Co's 13F filing for Q4 2020, filed 11 Jan 2021.